Publications by authors named "M Gillard"

Claim this Profile
R
Rapid expression of therapeutic antibodies in mammalian cells via mRNA transfection.
Thornwit Chavalparit, Craig Barry, Helen Gunter, Marianne Gillard, Timothy Mercer

MAbs· December 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of a SARS-CoV-2 spike, subunit vaccine stabilised in the prefusion conformation by second generation Molecular Clamp evaluated in adults aged 18-55 years: a randomised, double-blind, active comparator, Phase I trial.
Keith J Chappell, Francesca L Mordant, Alberto A Amarilla, Naphak Modhiran, Benjamin Liang, Marianne Gillard

J Infect Dis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel chimeric coronavirus spike vaccine combining SARS-CoV-2 RBD and scaffold domains from HKU-1 elicits potent neutralising antibody responses.
Veronica P Zoest, Wen Shi Lee, Lydia Murdiyarso, Lauren Burmas, Phillip Pymm, Marianne Gillard

NPJ Vaccines· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanisms underlying allosteric modulation of antiseizure medication binding to synaptic vesicle protein 2A (SV2A).
Anshumali Mittal, Matthew F Martin, Laurent Provins, Adrian Hall, Marie Ledecq, Michel Gillard

Proc Natl Acad Sci U S A· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A second-generation molecular clamp stabilised bivalent candidate vaccine for protection against diseases caused by respiratory syncytial virus and human metapneumovirus.
Andrew Young, Sharada Kolekar, Carlos Alvarez Mendoza, Noushin Jaberolansar, Naphak Modhiran, Marianne Gillard

PLoS Pathog· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis